adempas - riociguat tablet, film coated
(Riociguat)Bayer Healthcare Pharmaceuticals Inc.
Usage: Adempas treats adults with persistent/recurrent or inoperable chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 4) and pulmonary arterial hypertension (PAH, WHO Group 1) to improve exercise capacity, WHO functional class, and delay clinical worsening.